BIOMARKER DEVELOPMENT TO REFINE AN INDIVIDUALIZED RISK- ADAPTED APPROACH TO BLADDER-SPARING TREATMENT FOR MUSCLE-INVASIVE BLADDER CANCER

Icahn School Of Medicine At Mount Sinai, New York NY

Investigators